Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a confirmed diagnosis of stable heart failure with preserved ejection fraction (a type of heart failure where the heart pumps normally but is too stiff), and whose heart failure medications have not changed in the past month
- People whose heart has been shown in the past 12 months to pump out more than 50% of its blood with each beat (a measure of heart function)
- People who have a confirmed diagnosis of Type 2 diabetes with a blood sugar control reading (HbA1c) below 10%, and whose diabetes medications have not changed in the past month
Who may not be able to join:
- People who are currently taking pre- or probiotic supplements
- People who have taken antibiotics in the past 6 months
- People who are currently taking part in another clinical trial that involves a treatment or intervention
- People who have a history of allergy to potato or potato starch, or who have irritable bowel syndrome, inflammatory bowel disease, bowel resection surgery, Roux-en-Y gastric bypass surgery, coeliac disease, Crohn's disease, or colorectal cancer
- People who have had a low blood sugar episode in the past month
- People who have advanced chronic kidney disease (stage 4 or 5)
- People who are pregnant (based on self-report)
- People who have another serious illness that is expected to limit survival to less than 12 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Scott Hummel, MD, MS, University of Michigan
Phone: 734-726-0308
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in Short Chain Fatty Acid (SCFA) butyrate levels - stool; Changes in Short Chain Fatty Acid (SCFA) butyrate levels - plasma; Changes in propionate levels - stool; Changes in propionate levels- plasma; Changes in acetate levels- stool; Changes in acetate levels- plasma
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.